Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Annales Pharmaceutiques Francaises
|
November 27, 2012
[Vaccination and French community pharmacists: from innovative actions to innovative organisations?]
F Megerlin
Annales Pharmaceutiques Francaises
|
October 1, 2013
[Conditional pricing for innovative medicines in France: stop telling about risk-sharing!]
F Megerlin
Annales Pharmaceutiques Francaises
|
May 12, 2020
[Cov19, seroprevalence studies and Individuals Protection Committees: aren't the technological and organizational challenges enough ?]
C Huriet, F Megerlin
Annales Pharmaceutiques Francaises
|
July 15, 2020
[Research activities involving human beings & French governmental order April 2020 within Cov19 context: What input?]
C Huriet, F Megerlin
Annales Pharmaceutiques Francaises
|
September 16, 2014
[Faecal microbiota transplantation in France: what applicable law?]
F Megerlin, E Fouassier
Annales Pharmaceutiques Francaises
|
July 7, 2014
Faecal microbiota transplantation: a sui generis biological drug, not a tissue
F Megerlin, E Fouassier, R Lopert, et al.
Annales Pharmaceutiques Francaises
|
November 27, 2012
[Community pharmacist and vaccination: actuality and opportunity]
R Moreau, H Lepage, F Blanchet, et al.
Annales Pharmaceutiques Francaises
|
October 9, 2016
Benefits of pharmacist-led flu vaccination services in community pharmacy
C L Kirkdale, G Nebout, F Megerlin, et al.
Annales Pharmaceutiques Francaises
|
September 16, 2014
[Why could gut microbiota become a medication?]
P Bourlioux, F Megerlin, G Corthier, et al.
Annales Pharmaceutiques Francaises
|
April 1, 2015
[Fecal microbiota transplantation in recurrent Clostridium difficile infections. Framework and pharmaceutical preparation aspects]
R Batista, N Kapel, F Megerlin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Annales Pharmaceutiques Francaises
|
November 27, 2012
[Vaccination and French community pharmacists: from innovative actions to innovative organisations?]
F Megerlin
Annales Pharmaceutiques Francaises
|
October 1, 2013
[Conditional pricing for innovative medicines in France: stop telling about risk-sharing!]
F Megerlin
Annales Pharmaceutiques Francaises
|
May 12, 2020
[Cov19, seroprevalence studies and Individuals Protection Committees: aren't the technological and organizational challenges enough ?]
C Huriet, F Megerlin
Annales Pharmaceutiques Francaises
|
July 15, 2020
[Research activities involving human beings & French governmental order April 2020 within Cov19 context: What input?]
C Huriet, F Megerlin
Annales Pharmaceutiques Francaises
|
September 16, 2014
[Faecal microbiota transplantation in France: what applicable law?]
F Megerlin, E Fouassier
Annales Pharmaceutiques Francaises
|
July 7, 2014
Faecal microbiota transplantation: a sui generis biological drug, not a tissue
F Megerlin, E Fouassier, R Lopert, et al.
Annales Pharmaceutiques Francaises
|
November 27, 2012
[Community pharmacist and vaccination: actuality and opportunity]
R Moreau, H Lepage, F Blanchet, et al.
Annales Pharmaceutiques Francaises
|
October 9, 2016
Benefits of pharmacist-led flu vaccination services in community pharmacy
C L Kirkdale, G Nebout, F Megerlin, et al.
Annales Pharmaceutiques Francaises
|
September 16, 2014
[Why could gut microbiota become a medication?]
P Bourlioux, F Megerlin, G Corthier, et al.
Annales Pharmaceutiques Francaises
|
April 1, 2015
[Fecal microbiota transplantation in recurrent Clostridium difficile infections. Framework and pharmaceutical preparation aspects]
R Batista, N Kapel, F Megerlin, et al.
Page
of 2